A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Duchenne Muscular Dystrophy

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Arkansas Children's Hospital, Little Rock, Arkansas, United States

    Contact: Study coordinator (Amber Kellogg) · aveerapandiyan@uams.edu · 501-364-3389
    Contact: Principal Investigator (Aravindhan Veerapandiyan, MD)
  • University of California, Los Angeles Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Ummi Qasim) · UQasim@mednet.ucla.edu · 310-825-3264
    Contact: Principal Investigator (Perry Shieh, MD, PhD)
  • University of California, Davis, Sacramento, California, United States

    Contact: Study coordinator (Neuromuscular Research Lab) · NMRL@ucdavis.edu · 916-734-5057
    Contact: Principal Investigator (Craig McDonald, MD)
  • University of California, San Diego, California, United States

    Contact: Study coordinator (Gabriella Penner) · gpenner@health.ucsd.edu · 858-382-3061
    Contact: Principal Investigator (Chamindra Laverty, MD)
  • Rare Disease Research, Atlanta, Georgia, United States

    Contact: Principal Investigator (Renata Shih, MD)
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Alka Maheshwari) · amaheshwari@luriechildrens.org · 312-227-3813
    Contact: Study coordinator (Nancy Kuntz, MD)
  • Washington University in St. Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Natalie Goedeker) · neuromusclepediatricresearch@wustl.edu · 314-362-4919
    Contact: Principal Investigator (Craig Zaidman, MD)
  • Nationwide Children's Hospital, Columbus, Ohio, United States

    Contact: Study coordinator (Destany McCain) · dbs001@nationwidechildrens.org · 614-722-6961
    Contact: Principal Investigator (Kevin Flanigan, MD)
  • Oregon Health and Sciences University, Portland, Oregon, United States

    Contact: Study coordinator (Beata Dyar) · dyar@ohsu.edu · 503-494-8216
    Contact: Principal Investigator (Erika Finanger, MD)
  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Brandt Parlanti) · parlantib@chop.edu · 215-850-7769
    Contact: Principal Investigator (John Brandsema, MD)
  • Children's Hospital of the King's Daughters, Norfolk, Virginia, United States

    Contact: Study coordinator (E.Ann Walker) · Proud.Research@CHKD.org · 757-668-6543
    Contact: Principal Investigator (Crystal Proud, MD)
  • Seattle Children's Hospital, Seattle, Washington, United States

    Contact: Study coordinator (Janaki O'Brien) · Janaki.OBrien@seattlechildrens.org · 206-987-1642
    Contact: Principal Investigator (Alicia Henriquez, MD)
  • The Hospital for Sick Children, Toronto, Ontario, Canada

    Contact: Study coordinator (Ana Stosic) · Ana.Stosic@SickKids.ca · 416-648-6831
    Contact: Principal Investigator (Hernan Gonorazky, MD)
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    Contact: Study coordinator (Lorenzo Stivala) · lorenzo.stivala@policlinicogemelli.it · +39 063-015-6330
    Contact: Principal Investigator (Eugenio Mercuri, MD, PhD)
  • Great Ormond Street Hospital, London, United Kingdom

    Contact: Study coordinator (Lucinda Furtado) · Lucinda.furtado@gosh.nhs.uk · +44 (0)20 7762 6932
    Contact: Principal Investigator (Francesco Muntoni, MD)
מובילי המחקר
  • Solid Bio Clinical Trials

    Study Director

    Solid Biosciences